Fox Chase Cancer Center Appoints Harry S. Cooper, M.D. Vice-Chairman Department of Pathology
PHILADELPHIA (March 5, 2002) -- Harry S. Cooper, MD, of Wyndmoor, Pa., has been appointed vice chairman of the Department of Pathology at Fox Chase Cancer Center. Cooper most recently was director of the clinical laboratories of Fox Chase Cancer Center. Cooper will assist the department chairman with administrative duties, while maintaining his role as director of the clinical laboratories.
Cooper is nationally recognized as an outstanding surgical pathologist with a particular interest in diseases of the gastrointestinal tract. He has lectured widely throughout the United States and abroad and is the author of 70 research papers as well as numerous chapters on gastrointestinal pathology in leading pathology textbooks. His current research interests pertain to colon carcinogenesis and chemoprevention.
He serves on the editorial boards of The American Journal of Surgical Pathology and Human Pathology. He is a past president of the Pathology Society of Philadelphia, the Gastrointestinal Pathology Society of the United States and the Canadian Academy of Pathology.
Cooper is board certified by the American Board of Pathology in anatomic and clinical pathology and in immunopathology. He joined the pathology staff at Fox Chase, where he is also a senior member of the medical science division, in 1994. Previously he was a professor and director of anatomic pathology at Hahnemann University Hospital, and professor and director of surgical pathology at Thomas Jefferson University Hospital.
Cooper received his BA degree from Temple University and graduated from Jefferson Medical College in 1972. His completed his internship and residency in pathology at Johns Hopkins Hospital in Baltimore and at the Hospital of the University of Pennsylvania.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at www.fccc.edu.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.